Y Courtney

Learn More
BACKGROUND Memantine, an NMDA antagonist, is effective for moderate to severe Alzheimer's disease. OBJECTIVE Determine whether memantine improves cognitive performance (CP) among subjects with multiple sclerosis (MS) and cognitive impairment (CI). METHODS This double-blind, randomized, placebo-controlled trial (Clinicaltrials.gov NCT00300716) compared(More)
  • 1